The active ingredient in Lipozem has been the subject of conflicting research findings. Read this review to see whether these ...

Similar to the first Phase 3 trial, ORCA-3 participants had an average age of 53 years, smoked a median of 20 cigarettes per day at baseline, and had a median smoking history of 36 years with four ...

Miami. Florida, April 21, 2025 (GLOBE NEWSWIRE) -- In a recent industry-wide review conducted on kratom brands, On Pattison, a leading news publication, recognized Happy Go Leafy (HGL) as the best ...

The ‘9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East’ was held April 18-20, 2025 in Abu Dhabi, United Arab Emirates (UAE). The meeting convened clinicians ...

A Phase 2 study evaluating TPST-1495 in patients with FAP is set to begin this year, conducted by the Cancer Prevention Clinical Trials Network and funded by the National Cancer Institute (NCI) ...

The data will showcase the potential of AP402, a first-in-class, next generation T cell engager targeting CD137 and p95HER2 in in-vivo and in vitro studies. AP402 recently received IND clearance to ...

Douglas Thorburn, MD, Divisional Clinical Director for Liver and Digestive Health at the Royal Free London NHS Trust and Professor of Hepatology in the Institute for Liver and Digestive Health at UCL ...

Additionally, Reflect Scientific is implementing operational cost-saving measures that are projected to yield annual savings between $200,000 and $300,000. These initiatives underline the Company's ...

GenesisX pairs clinical capability with broad accessibility in surgical robotics. ST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global lead ...

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable ...

Proposed bipartisan legislation would expand Medicare reimbursement pathways for AI-enabled medical devices — a framework that supports Nexalin’s Gen-3 HALO Clarity™ neurostimulation device integrated ...

In addition to the progress in silk production, Kraig Labs has completed the production of all BAM-1 hybrid eggs designated for release over the next month. This achievement ensures a steady supply of ...